WO1992001814A3 - Reduction d'amplification non-specifique au cours d'une amplification in vitro d'acide nucleique utilisant des bases d'acide nucleique modifiees - Google Patents

Reduction d'amplification non-specifique au cours d'une amplification in vitro d'acide nucleique utilisant des bases d'acide nucleique modifiees Download PDF

Info

Publication number
WO1992001814A3
WO1992001814A3 PCT/US1991/005210 US9105210W WO9201814A3 WO 1992001814 A3 WO1992001814 A3 WO 1992001814A3 US 9105210 W US9105210 W US 9105210W WO 9201814 A3 WO9201814 A3 WO 9201814A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
amplification
reduction
specific amplification
vitro
Prior art date
Application number
PCT/US1991/005210
Other languages
English (en)
Other versions
WO1992001814A2 (fr
Inventor
John J Sninsky
David H Gelfand
Shirley Y Kwok
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Priority to JP51560491A priority Critical patent/JP3392863B2/ja
Priority to AU85327/91A priority patent/AU665338B2/en
Priority to DK91916353T priority patent/DK0540693T3/da
Priority to EP91916353A priority patent/EP0540693B1/fr
Priority to US07/960,362 priority patent/US5418149A/en
Priority to DE69130800T priority patent/DE69130800T2/de
Priority to CA002087724A priority patent/CA2087724C/fr
Publication of WO1992001814A2 publication Critical patent/WO1992001814A2/fr
Publication of WO1992001814A3 publication Critical patent/WO1992001814A3/fr
Priority to GR990401066T priority patent/GR3029987T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Des procédés améliorés d'amplification d'acides nucléiques peuvent réduire l'amplification non-spécifique et minimiser les effets de contamination d'analyses de réactions d'amplification d'acide nucléique dus à des produits amplifiés provenant des précédentes amplifications. Ces procédés consistent à introduire des bases de nucléotides non conventionnelles dans les produits de réaction d'amplification et à traiter les produits au moyen d'éléments enzymatiques (par exemple des glycosylases) et/ou physiques-chimiques afin que le produit soit incapable d'agir comme une matrice dans des amplifications subséquentes.
PCT/US1991/005210 1990-07-24 1991-07-23 Reduction d'amplification non-specifique au cours d'une amplification in vitro d'acide nucleique utilisant des bases d'acide nucleique modifiees WO1992001814A2 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP51560491A JP3392863B2 (ja) 1990-07-24 1991-07-23 修飾核酸塩基を使用するインビトロ核酸増幅における非特異的増幅の低減
AU85327/91A AU665338B2 (en) 1990-07-24 1991-07-23 The reduction of non-specific amplification during (in vitro) nucleic acid amplification using modified nucleic acid bases
DK91916353T DK0540693T3 (da) 1990-07-24 1991-07-23 Reduktion af ikke-specifik amplifikation under in vitro-nukleinsyreamplifikation under anvendelse af modificerede nukleinsy
EP91916353A EP0540693B1 (fr) 1990-07-24 1991-07-23 REDUCTION D'AMPLIFICATION NON-SPECIFIQUE AU COURS D'UNE AMPLIFICATION $i(IN VITRO) D'ACIDE NUCLEIQUE UTILISANT DES BASES D'ACIDE NUCLEIQUE MODIFIEES
US07/960,362 US5418149A (en) 1990-07-24 1991-07-23 Reduction of non-specific amplification glycosylase using DUTP and DNA uracil
DE69130800T DE69130800T2 (de) 1990-07-24 1991-07-23 Verringerung von nicht spezifischer amplifikation während einer (in vitro) nukleinsäure amplifikation unter verwendung von modifizierten nukleinsäure basen
CA002087724A CA2087724C (fr) 1990-07-24 1991-07-23 Reduction de l'amplification non specifique lors de l'amplification de l'acide nucleique in vitro grace a des bases d'acide nucleique modifiees
GR990401066T GR3029987T3 (en) 1990-07-24 1999-04-19 THE REDUCTION OF NON-SPECIFIC AMPLIFICATION DURING -i(IN VITRO) NUCLEIC ACID AMPLIFICATION USING MODIFIED NUCLEIC ACID BASES

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55751790A 1990-07-24 1990-07-24
US557,517 1990-07-24
US60915790A 1990-11-02 1990-11-02
US609,157 1990-11-02

Publications (2)

Publication Number Publication Date
WO1992001814A2 WO1992001814A2 (fr) 1992-02-06
WO1992001814A3 true WO1992001814A3 (fr) 1992-05-14

Family

ID=27071456

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1991/005210 WO1992001814A2 (fr) 1990-07-24 1991-07-23 Reduction d'amplification non-specifique au cours d'une amplification in vitro d'acide nucleique utilisant des bases d'acide nucleique modifiees

Country Status (11)

Country Link
US (1) US5418149A (fr)
EP (1) EP0540693B1 (fr)
JP (1) JP3392863B2 (fr)
AT (1) ATE176002T1 (fr)
AU (1) AU665338B2 (fr)
CA (1) CA2087724C (fr)
DE (1) DE69130800T2 (fr)
DK (1) DK0540693T3 (fr)
ES (1) ES2128323T3 (fr)
GR (1) GR3029987T3 (fr)
WO (1) WO1992001814A2 (fr)

Families Citing this family (179)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5035996A (en) * 1989-06-01 1991-07-30 Life Technologies, Inc. Process for controlling contamination of nucleic acid amplification reactions
US5683896A (en) * 1989-06-01 1997-11-04 Life Technologies, Inc. Process for controlling contamination of nucleic acid amplification reactions
US5856088A (en) * 1989-07-11 1999-01-05 Gen-Probe Incorporated Detection of human immunodeficiency virus type 1
US6589734B1 (en) 1989-07-11 2003-07-08 Gen-Probe Incorporated Detection of HIV
KR100325554B1 (ko) 1993-03-26 2002-11-02 젠-프로브 인코포레이티드 사람의면역결핍 바이러스타입1의검출
CA2122203C (fr) * 1993-05-11 2001-12-18 Melinda S. Fraiser Decontamination des reactions d'amplification d'acides nucleiques
ATE205259T1 (de) * 1993-07-01 2001-09-15 Hoffmann La Roche Reagenz und verfahren für reverse transkription bei hoher temperatur, verbunden mit einer polymerase-kettenreaktion
EP1245286B1 (fr) * 1993-10-22 2009-11-25 Abbott Laboratories Tube de réaction et méthode d'utilisation de celui-ci minimisant les contaminations
US6309883B1 (en) 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US20060257890A1 (en) * 1996-05-20 2006-11-16 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6995017B1 (en) 1994-02-17 2006-02-07 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6395547B1 (en) 1994-02-17 2002-05-28 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6406855B1 (en) * 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
DE4412286A1 (de) * 1994-04-09 1995-10-12 Boehringer Mannheim Gmbh System zur kontaminationsfreien Bearbeitung von Reaktionsabläufen
FR2722799B1 (fr) * 1994-07-21 1996-10-04 Parteurop Procede d'amplification d'acide nucleique a l'aide d'un nucleoside modifie, et detection du produit d'amplification a l'aide d'anticorps
ZA956776B (en) 1994-08-25 1996-03-20 Akzo Nobel Nv A process for making the product of a nucleic acid amplification reaction incapable of being a target for further amplification a diagnostic assay employing said process a kit and a container suitable for carrying out said process for assay
CA2168712A1 (fr) * 1995-02-07 1996-08-08 John William Henderson Sutherland Utilisation d'exonuclease et (ou) de glycosylate comme supplements d'anticorps anti-polymerase pour augmenter la specificite dans les reactions en chaine de la polymerase
US5932450A (en) * 1995-06-07 1999-08-03 Gen-Probe Incorporated Enzymatic synthesis of oligonucleotides using digestible templates
US5916777A (en) * 1995-06-07 1999-06-29 Gen-Probe Incorporated Enzymatic synthesis of oligonucleotides using 3'-ribonucleotide primers
EP0832280A2 (fr) * 1995-06-07 1998-04-01 Abbott Laboratories Procede de masquage de sonde servant a limiter le signal d'arriere-plan dans une reaction d'amplification
DE69527444T3 (de) * 1995-07-11 2007-08-16 Forfas (Trading As Bioresearch Ireland) Glycosylase verwendende detektion von bestimmten nukleinsäuresequenzen
US6190865B1 (en) * 1995-09-27 2001-02-20 Epicentre Technologies Corporation Method for characterizing nucleic acid molecules
US5837442A (en) 1995-11-29 1998-11-17 Roche Molecular Systems, Inc. Oligonucleotide primers for amplifying HCV nucleic acid
DE19545320A1 (de) * 1995-12-05 1997-06-12 Boehringer Mannheim Gmbh Thermolabile Uracil-DNA-Glykosylase, Verfahren zu deren Herstellung und Verwendung zur Entfernung von Uracil aus DNA
US5763184A (en) 1996-01-30 1998-06-09 Roche Molecular Systems, Inc. Nucleotide sequence variation in the ABO glycosyltransferase gene
US6852487B1 (en) * 1996-02-09 2005-02-08 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US20020150921A1 (en) * 1996-02-09 2002-10-17 Francis Barany Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US6506602B1 (en) 1996-03-25 2003-01-14 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6413718B1 (en) 1996-05-01 2002-07-02 Visible Genetics Inc. Method for sequencing of nucleic acid polymers
US6436638B1 (en) 1996-05-09 2002-08-20 Metropolitan Water District Of Southern California Cryptosporidium detection method
CA2255774C (fr) * 1996-05-29 2008-03-18 Cornell Research Foundation, Inc. Detection de differences dans des sequences d'acides nucleiques utilisant une combinaison de la detection par ligase et de reactions d'amplification en chaine par polymerase
US6017702A (en) * 1996-12-05 2000-01-25 The Perkin-Elmer Corporation Chain-termination type nucleic acid sequencing method including 2'-deoxyuridine-5'-triphosphate
US20070009930A1 (en) * 1996-12-18 2007-01-11 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5861295A (en) 1997-01-02 1999-01-19 Life Technologies, Inc. Nucleic acid-free thermostable enzymes and methods of production thereof
US6117634A (en) * 1997-03-05 2000-09-12 The Reagents Of The University Of Michigan Nucleic acid sequencing and mapping
US6197557B1 (en) 1997-03-05 2001-03-06 The Regents Of The University Of Michigan Compositions and methods for analysis of nucleic acids
ES2230631T3 (es) * 1997-03-20 2005-05-01 F. Hoffmann-La Roche Ag Cebadores modificados.
US5958738A (en) * 1997-03-24 1999-09-28 Roche Diagnostics Corporation Procedure for subtractive hybridization and difference analysis
US6153410A (en) * 1997-03-25 2000-11-28 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
DE19736062A1 (de) * 1997-08-20 1999-02-25 Boehringer Mannheim Gmbh Reduktion von Kreuzkontaminationen bei Nukleinsäureamplifikationen
DK1036198T3 (da) 1997-12-08 2013-01-02 California Inst Of Techn Fremgangsmåde til fremstilling af polynukleotid- og polypeptidsekvenser
JP4388694B2 (ja) * 1998-02-04 2009-12-24 アプライド バイオシステムズ， エルエルシー 複数のアレル部位における増幅産物のゲノム型決定
US6174680B1 (en) 1998-12-30 2001-01-16 Dana-Farber Cancer Institute, Inc. Method for identifying mismatch repair glycosylase reactive sites, compounds and uses thereof
CA2321119A1 (fr) * 1998-02-23 1999-08-26 Dana-Farber Cancer Institute, Inc. Procede permettant d'identifier les sites reactifs des glycosylases de reparation des mesappariements, compose et utilisations de ce dernier
JP4196236B2 (ja) * 1998-03-17 2008-12-17 東洋紡績株式会社 核酸増幅用試薬および配列特異的な核酸増幅法
WO1999050447A1 (fr) * 1998-03-27 1999-10-07 Mira Diagnostika Gmbh Procede et compose d'acide nucleique pour la decomposition de molecules d'acide nucleique synthetisees in vitro
CA2266755A1 (fr) * 1998-04-24 1999-10-24 James M. Dunn Methode de sequencage de polymeres d'acides nucleiques
US6365408B1 (en) 1998-06-19 2002-04-02 Maxygen, Inc. Methods of evolving a polynucleotides by mutagenesis and recombination
US7270958B2 (en) * 1998-09-10 2007-09-18 The Regents Of The University Of Michigan Compositions and methods for analysis of nucleic acids
JP2002538415A (ja) 1998-12-30 2002-11-12 デイナ−ファーバー キャンサー インスティチュート，インコーポレイテッド 変異走査アレイ、およびその使用方法
US6506594B1 (en) * 1999-03-19 2003-01-14 Cornell Res Foundation Inc Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
EP1038974A1 (fr) * 1999-03-26 2000-09-27 Mira Diagnostica GmbH Procédé, oligonucleotides pour la dégradation des acides nucléiques synthétisés in vitro
EP1041159A3 (fr) * 1999-03-26 2000-10-25 MIRA Diagnostika GmbH Procédé, oligonucléotides pour la dégradation des acides nucléiques synthétisés in vitro
US6509157B1 (en) * 1999-11-05 2003-01-21 Roche Molecular Systems, Inc 3 blocked nucleic acid amplification primers
WO2001036679A2 (fr) * 1999-11-15 2001-05-25 Hartwell John G METHODES DE GENERATION DE FRAGMENTS D'ADNc SIMPLE BRIN
WO2001079548A2 (fr) 2000-04-14 2001-10-25 Cornell Research Foundation, Inc. Procede de conception d'un reseau adressable dans la detection de differences de sequences d'acides nucleiques, au moyen d'une reaction de detection de ligase
EP1307469B1 (fr) * 2000-08-03 2008-01-23 Boehringer Mannheim Gmbh Composes de fixation d'acides nucleiques contenant des analogues pyrazolo¬3,4-d pyrimidine de purine 2,6-diamine et leurs utilisations
IL155450A0 (en) * 2000-10-20 2003-11-23 Expression Diagnostics Inc Leukocyte expression profiling
US20020165673A1 (en) * 2001-01-19 2002-11-07 Allen Morgan Method of self-sampling and analyzing a semen sample
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7222059B2 (en) * 2001-11-15 2007-05-22 Siemens Medical Solutions Diagnostics Electrophoretic trace simulator
US8030000B2 (en) 2002-02-21 2011-10-04 Alere San Diego, Inc. Recombinase polymerase amplification
US7399590B2 (en) 2002-02-21 2008-07-15 Asm Scientific, Inc. Recombinase polymerase amplification
EP1992706B1 (fr) 2002-02-21 2014-11-19 Alere San Diego, Inc. Amplification par recombinase et polymérase
GB0205455D0 (en) 2002-03-07 2002-04-24 Molecular Sensing Plc Nucleic acid probes, their synthesis and use
US20040241723A1 (en) * 2002-03-18 2004-12-02 Marquess Foley Leigh Shaw Systems and methods for improving protein and milk production of dairy herds
JP4551216B2 (ja) * 2002-05-17 2010-09-22 ニューゲン テクノロジーズ， インコーポレイテッド 核酸の断片化、標識および固定化の方法
US7273730B2 (en) * 2002-05-24 2007-09-25 Invitrogen Corporation Nested PCR employing degradable primers
EP2390352A1 (fr) 2003-03-18 2011-11-30 Quantum Genetics Ireland Limited Systemes et procedes pour accroitre la production de proteines et de lait chez des bovins laitiers
WO2004094986A2 (fr) * 2003-04-16 2004-11-04 Handylab, Inc. Systeme et procede de detection electrochimique de composes biologiques
US7892745B2 (en) * 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US20050123956A1 (en) * 2003-09-25 2005-06-09 Affymetrix, Inc. Methods for modifying DNA for microarray analysis
AU2004311882A1 (en) 2003-12-29 2005-07-21 Nugen Technologies, Inc. Methods for analysis of nucleic acid methylation status and methods for fragmentation, labeling and immobilization of nucleic acids
ATE452992T1 (de) * 2004-02-04 2010-01-15 Qiagen North American Holdings Zusammensetzungen auf dutp-basis zurverringerung der primeraggregatbildung während der nukleinsäureamplifikation
US20050191682A1 (en) * 2004-02-17 2005-09-01 Affymetrix, Inc. Methods for fragmenting DNA
AU2005244673B2 (en) 2004-02-19 2009-12-10 The Governors Of The University Of Alberta Leptin promoter polymorphisms and uses thereof
US20080311627A1 (en) * 2004-06-17 2008-12-18 Epigenomics Ag Compositions and Methods for Preventing Carry-Over Contamination in Nucleic Acid Amplification Reactions
WO2006029184A2 (fr) * 2004-09-08 2006-03-16 Expression Diagnostics, Inc. Genes permettant de diagnostiquer et de surveiller les troubles associes a l'inflammation
US20060068430A1 (en) * 2004-09-20 2006-03-30 Sigma-Aldrich Co. Purification of biomolecules from contaminating intact nucleic acids
US7642055B2 (en) 2004-09-21 2010-01-05 Applied Biosystems, Llc Two-color real-time/end-point quantitation of microRNAs (miRNAs)
WO2006058393A1 (fr) * 2004-12-03 2006-06-08 Human Genetic Signatures Pty Ltd Procedes de simplification d’acides nucleiques microbiens par modification chimique de cytosines
WO2006122295A2 (fr) * 2005-05-11 2006-11-16 Expression Diagnostics, Inc. Procedes de surveillance de l'etat fonctionnel de transplants a l'aide de panels de genes
AU2006251866B2 (en) * 2005-05-26 2007-11-29 Human Genetic Signatures Pty Ltd Isothermal strand displacement amplification using primers containing a non-regular base
DK1920064T3 (da) * 2005-07-07 2015-03-30 Quanta Biosciences Inc Sammensætninger og fremgangsmåder til forøgelse af amplifikationseffektiviteten
EP2829615B1 (fr) 2005-07-25 2018-05-09 Alere San Diego, Inc. Trousse de multiplexage de l'amplification par recombinase polymérase
WO2007030882A1 (fr) * 2005-09-14 2007-03-22 Human Genetic Signatures Pty Ltd Essai pour un état de santé
US20070212704A1 (en) 2005-10-03 2007-09-13 Applera Corporation Compositions, methods, and kits for amplifying nucleic acids
US20070087059A1 (en) * 2005-10-17 2007-04-19 Frank Everaerts Bioactive delivery matrix compositions and methods
EP2007909A4 (fr) * 2006-04-07 2011-01-26 Xdx Inc Expression d'acide nucleique en reponse aux steroides et prevision de l'activite d'une maladie
US8206923B2 (en) 2006-04-24 2012-06-26 Elvira Garza Gonzalez Method for detection and multiple, simultaneous quantification of pathogens by means of real-time polymerase chain reaction
EP2021506B1 (fr) 2006-04-28 2016-03-16 Igor Kutyavin Utilisation de produits d'amplification pcr portant des elements de structure secondaire pour ameliorer la detection d'acides nucleiques par pcr
CA2650820C (fr) 2006-04-28 2014-09-16 Igor Kutyavin Utilisation de desoxynucleoside triphosphates a base modifiee pour la detection d'acides nucleiques
JP2009535053A (ja) 2006-05-04 2009-10-01 エーエスエム サイエンティフィック， インコーポレイテッド レコンビナーゼポリメラーゼ増幅
EP2038429B1 (fr) * 2006-06-30 2013-08-21 Nugen Technologies, Inc. Procédés de fragmentation et de marquage d'acides nucléiques
US7501254B2 (en) * 2006-07-20 2009-03-10 Ghc Technologies, Inc. Methods and compositions for amplification and capture of nucleic acid sequences
US7993832B2 (en) * 2006-08-14 2011-08-09 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
US8148067B2 (en) * 2006-11-09 2012-04-03 Xdx, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
US9938641B2 (en) * 2006-12-18 2018-04-10 Fluidigm Corporation Selection of aptamers based on geometry
FR2914317B1 (fr) * 2007-03-30 2012-12-28 Biomerieux Sa Methode de decontamination d'une solution des acides nucleiques indesirables
JP5431351B2 (ja) * 2007-11-27 2014-03-05 ヒューマン ジェネティック シグネチャーズ ピーティーワイ リミテッド バイサルファイト修飾された核酸を増幅およびコピーするための酵素
CA2707165A1 (fr) * 2007-12-05 2009-06-11 Human Genetic Signatures Pty Ltd Traitement de l'arn avec du bisulfite
EP2071034A1 (fr) 2007-12-12 2009-06-17 bioMérieux Procédé pour le traitement d'une solution en vue d'éliminer un acide ribonucléique après amplification
AU2008341021A1 (en) * 2007-12-20 2009-07-02 Human Genetic Signatures Pty Ltd Elimination of contaminants associated with nucleic acid amplification
US8669061B2 (en) * 2008-06-26 2014-03-11 Roche Molecular Systems, Inc. Method for the prevention of carryover contamination in nucleic acid amplification technologies
US8198023B2 (en) 2008-08-05 2012-06-12 Pacific Biosciences Of California, Inc. Prevention and alleviation of steric hindrance during single molecule nucleic acid synthesis by a polymerase
WO2010048386A1 (fr) * 2008-10-24 2010-04-29 Helicos Biosciences Corporation Procédés de préparation d’échantillon pour l’analyse d’acides nucléiques pour des acides nucléiques disponibles en quantités limitées
WO2010135310A1 (fr) * 2009-05-20 2010-11-25 Biosite Incorporated Glycosylase/lyase d'adn et substrats d'endonucléase ap
WO2010141940A1 (fr) 2009-06-05 2010-12-09 Alere San Diego, Inc. Réactifs et kits d'amplification par recombinase polymérase
EP2272976A1 (fr) 2009-07-06 2011-01-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Procédé de différentiation de brins de polynucléotide
GB2474225A (en) 2009-07-21 2011-04-13 Biotec Pharmacon Asa DNase for decontamination of reverse transcription and amplification reactions
US20120052495A1 (en) * 2010-08-30 2012-03-01 Samsung Techwin Co., Ltd. Oligonucleotides for detecting listeria monocytogenes and use thereof
US8563298B2 (en) 2010-10-22 2013-10-22 T2 Biosystems, Inc. NMR systems and methods for the rapid detection of analytes
BR122020001802B1 (pt) 2010-10-22 2021-05-18 T2 Biosystems, Inc métodos para detectar a presença de um patógeno em uma amostra de sangue total e para detectar um analito em uma amostra
JP5961247B2 (ja) 2011-04-07 2016-08-02 アリーア サン ディエゴ， インコーポレイテッド リコンビナーゼポリメラーゼ増幅混合物のモニタリング
JP5830286B2 (ja) 2011-07-12 2015-12-09 アークレイ株式会社 核酸の増幅検出方法およびキット
JP5977000B2 (ja) 2011-07-12 2016-08-24 アークレイ株式会社 核酸の増幅検出方法およびキット
CA2848144C (fr) 2011-09-07 2018-03-06 Human Genetic Signatures Pty Ltd Essai de detection moleculaire
CA2852949A1 (fr) 2011-10-19 2013-04-25 Nugen Technologies, Inc. Compositions et procedes pour l'amplification et le sequencage directionnels d'acide nucleique
US9115394B2 (en) 2011-12-22 2015-08-25 Roche Molecular Systems, Inc. Methods and reagents for reducing non-specific amplification
EP2807292B1 (fr) 2012-01-26 2019-05-22 Tecan Genomics, Inc. Compositions et procédés pour l'enrichissement en séquence d'acide nucléique ciblée et la génération d'une banque à efficacité élevée
GB2518078B (en) 2012-06-18 2015-04-29 Nugen Technologies Inc Compositions and methods for negative selection of non-desired nucleic acid sequences
US20150011396A1 (en) 2012-07-09 2015-01-08 Benjamin G. Schroeder Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
US10752949B2 (en) 2012-08-14 2020-08-25 10X Genomics, Inc. Methods and systems for processing polynucleotides
CN113528634A (zh) 2012-08-14 2021-10-22 10X基因组学有限公司 微胶囊组合物及方法
US10400280B2 (en) 2012-08-14 2019-09-03 10X Genomics, Inc. Methods and systems for processing polynucleotides
US9951386B2 (en) 2014-06-26 2018-04-24 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10323279B2 (en) 2012-08-14 2019-06-18 10X Genomics, Inc. Methods and systems for processing polynucleotides
US11591637B2 (en) 2012-08-14 2023-02-28 10X Genomics, Inc. Compositions and methods for sample processing
US10221442B2 (en) 2012-08-14 2019-03-05 10X Genomics, Inc. Compositions and methods for sample processing
US9701998B2 (en) 2012-12-14 2017-07-11 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10273541B2 (en) 2012-08-14 2019-04-30 10X Genomics, Inc. Methods and systems for processing polynucleotides
WO2014063051A2 (fr) 2012-10-18 2014-04-24 Idexx Laboratories, Inc. Témoins d'amplification d'acides nucléiques, kits et leurs procédés d'utilisation
DK2914743T3 (da) 2012-11-02 2019-10-14 Life Technologies Corp Udvinding, detektering og kvantificering af lille rna
EP3567116A1 (fr) 2012-12-14 2019-11-13 10X Genomics, Inc. Procédés et systèmes de traitement de polynucléotides
US10533221B2 (en) 2012-12-14 2020-01-14 10X Genomics, Inc. Methods and systems for processing polynucleotides
KR20200140929A (ko) 2013-02-08 2020-12-16 10엑스 제노믹스, 인크. 폴리뉴클레오티드 바코드 생성
US9822408B2 (en) 2013-03-15 2017-11-21 Nugen Technologies, Inc. Sequential sequencing
GB201312995D0 (en) 2013-07-19 2013-09-04 Atlas Genetics Ltd Methods and kits for specific nucleic acid amplification and detection
EP3068883B1 (fr) 2013-11-13 2020-04-29 Nugen Technologies, Inc. Compositions et procédés pour l'identification d'une lecture de séquençage en double
US9745614B2 (en) 2014-02-28 2017-08-29 Nugen Technologies, Inc. Reduced representation bisulfite sequencing with diversity adaptors
AU2015243445B2 (en) 2014-04-10 2020-05-28 10X Genomics, Inc. Fluidic devices, systems, and methods for encapsulating and partitioning reagents, and applications of same
EP3142712B1 (fr) 2014-05-13 2019-08-07 Rasirc, Inc. Procédé d'administration de peroxyde d'hydrogène pour décontaminer un matériau
CN113249435B (zh) 2014-06-26 2024-09-03 10X基因组学有限公司 分析来自单个细胞或细胞群体的核酸的方法
AU2015339148B2 (en) 2014-10-29 2022-03-10 10X Genomics, Inc. Methods and compositions for targeted nucleic acid sequencing
US9975122B2 (en) 2014-11-05 2018-05-22 10X Genomics, Inc. Instrument systems for integrated sample processing
WO2016114970A1 (fr) 2015-01-12 2016-07-21 10X Genomics, Inc. Procédés et systèmes de préparation de librairies de séquençage d'acide nucléique et librairies préparées au moyen de ceux-ci
WO2016138148A1 (fr) 2015-02-24 2016-09-01 10X Genomics, Inc. Procédés pour la couverture ciblée de séquences d'acides nucléiques
US10697000B2 (en) 2015-02-24 2020-06-30 10X Genomics, Inc. Partition processing methods and systems
EP3967768A1 (fr) 2015-03-13 2022-03-16 Life Technologies Corporation Compositions pour la capture, la détection et la quantification de petit nra
BR112017022329A2 (pt) 2015-04-17 2018-07-17 Univ California métodos para detectar aglutinação e composições para uso na prática do mesmo
JP6966681B2 (ja) 2015-04-24 2021-11-17 アティラ バイオシステムズ インコーポレイテッドAtila Biosystems Incorporated 限られたヌクレオチド組成を有するプライマーを用いた増幅
KR101605671B1 (ko) 2015-05-12 2016-03-23 주식회사 엔지노믹스 데옥시유리딘을 포함하는 폴리뉴클레오타이드를 이용한 핵산 증폭반응의 위양성 여부 확인 방법
WO2017096158A1 (fr) 2015-12-04 2017-06-08 10X Genomics, Inc. Procédés et compositions pour l'analyse d'acide nucléique
WO2017197338A1 (fr) 2016-05-13 2017-11-16 10X Genomics, Inc. Systèmes microfluidiques et procédés d'utilisation
EP3279337A1 (fr) 2016-08-04 2018-02-07 Servizo Galego de Saúde (SERGAS) Utilisation de sondes courtes entre 8 et 9 nucléotides dans des biotests multiplex
US10815525B2 (en) 2016-12-22 2020-10-27 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10550429B2 (en) 2016-12-22 2020-02-04 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10011872B1 (en) 2016-12-22 2018-07-03 10X Genomics, Inc. Methods and systems for processing polynucleotides
EP4310183A3 (fr) 2017-01-30 2024-02-21 10X Genomics, Inc. Procédés et systèmes de codage à barres de cellules uniques à base de gouttelettes
CN109526228B (zh) 2017-05-26 2022-11-25 10X基因组学有限公司 转座酶可接近性染色质的单细胞分析
US20180340169A1 (en) 2017-05-26 2018-11-29 10X Genomics, Inc. Single cell analysis of transposase accessible chromatin
US10155939B1 (en) * 2017-06-15 2018-12-18 New England Biolabs, Inc. Method for performing multiple enzyme reactions in a single tube
US11099202B2 (en) 2017-10-20 2021-08-24 Tecan Genomics, Inc. Reagent delivery system
CN111051523B (zh) 2017-11-15 2024-03-19 10X基因组学有限公司 功能化凝胶珠
US10829815B2 (en) 2017-11-17 2020-11-10 10X Genomics, Inc. Methods and systems for associating physical and genetic properties of biological particles
WO2019195166A1 (fr) 2018-04-06 2019-10-10 10X Genomics, Inc. Systèmes et procédés de contrôle de qualité dans un traitement de cellules uniques
MX2018008742A (es) 2018-07-16 2020-01-17 Sigma Alimentos Sa De Cv Metodo y kit de diagnostico para detectar multiple y simultaneamente una combinacion de bacterias gram positivas y/o bacterias gram negativas.
WO2021089643A1 (fr) 2019-11-04 2021-05-14 Mirnax Biosens, S.L. Amorce inverse bivalente
EP3901286A1 (fr) 2020-04-24 2021-10-27 Mirnax Biosens, S.L. Amorce inverse bivalente
US12059674B2 (en) 2020-02-03 2024-08-13 Tecan Genomics, Inc. Reagent storage system
WO2022232087A1 (fr) * 2021-04-30 2022-11-03 Nutcracker Therapeutics, Inc. Procédés pour effectuer une transcription in vitro à l'aide de dutp
WO2024146937A1 (fr) 2023-01-06 2024-07-11 Dna Script Procédés d'obtention d'acides nucléiques correctement assemblés

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989011548A1 (fr) * 1988-05-20 1989-11-30 Cetus Corporation Sondes specifiques a des sequences immobilisees
EP0401037A2 (fr) * 1989-06-01 1990-12-05 Life Technologies Inc. Procédé pour contrôler la contamination dans l'amplification des acides nucléiques
EP0415755A2 (fr) * 1989-09-01 1991-03-06 Life Technologies Inc. Procédé pour contrôler la contamination des réactions d'amplification des acides nucléiques dépendant des oligonucléotides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957858A (en) * 1986-04-16 1990-09-18 The Salk Instute For Biological Studies Replicative RNA reporter systems
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4873192A (en) * 1987-02-17 1989-10-10 The United States Of America As Represented By The Department Of Health And Human Services Process for site specific mutagenesis without phenotypic selection
CA1340807C (fr) * 1988-02-24 1999-11-02 Lawrence T. Malek Procede d'amplification d'une sequence d'acide nucleique
KR0148265B1 (ko) * 1988-12-16 1998-10-15 에프.지이.엠 헤르만스 자가-지속 서열 복제 시스템

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989011548A1 (fr) * 1988-05-20 1989-11-30 Cetus Corporation Sondes specifiques a des sequences immobilisees
EP0401037A2 (fr) * 1989-06-01 1990-12-05 Life Technologies Inc. Procédé pour contrôler la contamination dans l'amplification des acides nucléiques
EP0415755A2 (fr) * 1989-09-01 1991-03-06 Life Technologies Inc. Procédé pour contrôler la contamination des réactions d'amplification des acides nucléiques dépendant des oligonucléotides

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Biochemistry, vol. 22, 1983, American Chemical Society, D. SAGHER et al.: "Insertion of nucleotides opposite apurinic/apyrimidinic sites in deoxyribonucleic acid during in vitro synthesis: Uniquencess of adenine nucleotides", pages 4518-4526, see abstract; page 4520, column 2, lines 1-8 (cited in the application) *
Biotechnology, vol. 6, October 1988, P.M. LIZARDI et al.: "Exponential amplification of recombinant-RNA hybridization probes", pages 1197-1202, see abstract (cited in the application) *
Gene, vol. 93, 1 September 1990, Elsevier Science Publishers B.V. (Biomedical Division), M.C. LONGO et al.: "Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions", pages 125-128, see the whole document *
Genomics, vol. 4, 1989, Academic Press, Inc., D.Y. WU et al.: "The ligation amplification reaction (LAR)-amplification of sepcific DNA sequences using sequential rounds of template-dependent ligation", pages 560-569, see abstract (cited in the application) *
Proceedings of the National Academy of Sciences of USA, vol. 82, January 1985, T.A. KUNKEL: "Rapid and efficient site-specific mutagenesis without phenotypic selection", pages 488-492, see page 489, lines 18-41 (cited in the application) *
Proceedings of the National Academy of Sciences of USA, vol. 86, February 1989, D.Y. KWOH et al.: "Transcription-based amplification system and detection of amplified human immunodeficiency virus type 1 with a bead-based sandwich hybridization format", pages 1172-1177, see abstract (cited in the application) *
Proceedings of the National Academy of Sciences of USA, vol. 87, March 1990, J.C. GUATELLI et al.: "Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication", pages 1874-1878, see abstract (cited in the application) *

Also Published As

Publication number Publication date
CA2087724C (fr) 2003-09-16
EP0540693A1 (fr) 1993-05-12
CA2087724A1 (fr) 1992-01-25
DK0540693T3 (da) 1999-09-13
JP3392863B2 (ja) 2003-03-31
ATE176002T1 (de) 1999-02-15
GR3029987T3 (en) 1999-07-30
WO1992001814A2 (fr) 1992-02-06
EP0540693B1 (fr) 1999-01-20
JPH06501612A (ja) 1994-02-24
DE69130800D1 (de) 1999-03-04
US5418149A (en) 1995-05-23
AU8532791A (en) 1992-02-18
ES2128323T3 (es) 1999-05-16
DE69130800T2 (de) 1999-09-16
AU665338B2 (en) 1996-01-04

Similar Documents

Publication Publication Date Title
WO1992001814A3 (fr) Reduction d'amplification non-specifique au cours d'une amplification in vitro d'acide nucleique utilisant des bases d'acide nucleique modifiees
IL81219A0 (en) Method and kit for detecting viruses by amplification and hybridization of nucleic acid sequences and compositions containing such amplified sequences
EP1050587A3 (fr) Génération et amplification des acides nucléiques à partir des acides ribonucléiques
EP0269445A3 (fr) Procédé de détection des virus HTLVI et HTLVII par hybridation
PL325439A1 (en) Oligonucleotides, method of amplifying nuclein acid and set of means for acrrying out such amplification of nucleic acid
PL315803A1 (en) Chemically modified thermostable enzyme, method of obtaining same, method of amplifying nucleic acid, reaction mixture for pcr amplification and pcr set
FI924049A0 (fi) Foerfarande foer att saerskilja nukleinsyror med hjaelp av nukleotiddifferenser.
IL86724A0 (en) Transcription-based nucleic acid amplification/detection systems
AU5736194A (en) Improved method for amplification of targeted segments of nucleic acid using nested polymerase chain reaction
DE60022541T2 (de) Polynukleotid- amplifikationsverfahren
AU4339196A (en) Use of exonuclease and/or glycosylase as supplements to anti-polymerase antibody to increase specificity in polymerase chain reaction
AU1272995A (en) Protecting nucleic acids and methods of analysis
AT388174B (de) Verfahren zur vergaerung von kohlenhydrathaeltigen medien mit hilfe von bakterien
WO2002088387A3 (fr) Procede d'amplification
ATE440147T1 (de) Erhíhung der spezifität von nukleinsäureamplifizierungen durch trägernukleinsäuren
CA2073298A1 (fr) Procede de reduction de la contamination lors des reactions d'amplification d'acides nucleiques
EP0258666A3 (fr) Transformations enzymatiques microbiennes de chrysanthémol, lavandulol et d'alcools analogues en acides
Gelfand et al. Reduction of non-specific amplification glycosylase using DUTP and DNA uracil
MY111893A (en) Method for detecting a target nucleic acid
NL6912541A (en) Production of uricase useful in treating gout
ES2173782A1 (es) Procedimiento de cuantificacion de acidos nucleicos mediante amplificacion por reaccion en cadena de ligasa competitiva.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 2087724

Country of ref document: CA

Ref document number: 1991916353

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1991916353

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1991916353

Country of ref document: EP